Investor Presentaiton
Balance Sheet
RMB'million
Bank balances and cash
2020
17,763.8
1357.3
Year Ended 31 December
2019
4,232.6
462.5
Other financial assets-current
Trade receivables
475.4
247.9
Contract assets
2.2
Deposits, prepayments and other receivables
164.5
151.6
Inventories
705.7
358.6
Total Current Assets
9,466.7
Property, plant and equipment
1,584.1
Right-of-Use assets
327.1
Intangible assets
32.6
-
5,455.4
1,344.8
91.5
Cash balance
As of December 31, 2020, our total cash
increased to RMB8, 121.1 million
(equivalent to US$1.2 billion)
As of February 28, 2021, our total cash
was approximately US$1.8 billion.
Deposits for acquisition of property, plant and equipment 272.3
84.8
Other receivables and tax recoverables
139.3
252.0
Other financial assets
12.9
2.0
Total Non-current Assets
2,368.3
1,775.1
Total Assets
11,835.0
7,230.5
Trade payables
(120.6)
(84.3)
Other payables and accrued expenses
(973.7)
(885.0)
Contract liabilities
(120.4)
(41.7)
Borrowings
(255.0)
(17.0)
Lease liabilities
(16.2)
(15.6)
Total Current Liabilities
(1,485.9)
(1,043.6)
Contract liabilities
(588.1)
(581.8)
Borrowings-non
Government grants
Lease liabilities
Total Non-current Liabilities
Total Liabilities
Total Equity
Innovent
(45.8)
(16.5)
(925.2)
(808.0)
(10.2)
(24.5)
(1,569.3)
(1,430.8)
(3,055.2)
(2,474.4)
8,779.8
4,756.1
Note: Numbers may not add due to rounding
Confidential
Copyright©2021 Innovent Biologics
37
36View entire presentation